NFKB1 and cancer: More recently, we discovered NF-κB inhibitor dehydroxymethyl-epoxyquinomicin (DHMEQ) by molecular design based on the structure of naturally occurring epoxyquinomicin C. In the present review, we describe inhibition of early and late phases of cancer metastasis by DHMEQ.